Clinical trials: Blepharoptosis
- Condition Blepharoptosis
- Funder type Industry (pharma, biotech, devices)
- Accepts healthy volunteers yes
Blepharoptosis
A Pharmacokinetics (PK) Study in Healthy Adults
This is to characterize STN1013800 active ingredient bioavailability following multiple-dose ocular administration of STN1013800 to both eyes in healthy adults.
- Trial name
- NCT06911216
- Testing
- STN1013800 ophthalmic solution
- Where
- China
- Volunteers
- 8 people, healthy volunteers welcome
- Sponsor
- Santen Pharmaceutical Co., Ltd.